Womble Bond Dickinson continues to build its Boston-based life sciences IP team with the addition of science advisor Pallavi Banerjee, Ph.D.

Banerjee uses her background in cancer biology, cell biology and immunology to help life sciences clients develop strategic patent portfolios. She has experience in assisting a wide range of biotechnology companies and universities with IP due diligence and drafting and prosecution of patent applications with the USPTO and foreign jurisdictions.

She spent seven years as a research fellow at Boston Children’s Hospital and Harvard Medical School, where she studied the cellular and molecular mechanisms of diseases and how to identify therapeutic targets using in vitro and in vivo mechanisms. Her research included extensive work in improving cancer treatments. Her work has been published in a number of scientific journals, including the Journal of Biological Chemistry, Cancer Research, Cancer Letters, and International Immunology.

Womble Bond Dickinson’s Boston Life Sciences Team includes more than 12 IP attorneys, patent agents and science advisors who guide biotech, pharmaceutical and medical device companies in securing, protecting and monetizing their intellectual property.

Across the firm, Womble Bond Dickinson’s IP, Technology and Data Service Team includes more than 100 IP lawyers and patent agents in the UK and US. The team manages nearly 16,000 active patent matters, including issued and pending patents, throughout the world.

About Womble Bond Dickinson

Womble Bond Dickinson is a transatlantic law firm with more than 1,000 lawyers based in 27 UK and US office locations serving clients across every business sector. The firm provides core legal services including: Commercial, Corporate, Employment, Pensions, Dispute Resolution, Litigation, Finance, Banking, Restructuring, Insolvency, IP, Technology and Data, Private Wealth, Projects, Construction and Infrastructure, Real Estate and Regulatory Law.